Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -6,455 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 409 | N/A |
| Accounts receivable | N/A | N/A | N/A | -31 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -424 | N/A |
| Other Working Capital | N/A | N/A | N/A | 3,745 | N/A |
| Other Operating Activity | -1,990 | -553 | 343 | 3,896 | -1,465 |
| Operating Cash Flow | $-1,990 | $-553 | $343 | $1,140 | $-1,465 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -410 | -109 | -59 | -581 | -433 |
| Investing Cash Flow | $-410 | $-109 | $-59 | $-581 | $-433 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16 | 16 | N/A | 3,250 | 3,250 |
| Financing Cash Flow | $16 | $16 | $N/A | $3,250 | $3,250 |
| Beginning Cash Position | 12,897 | 12,897 | 12,897 | 9,684 | 9,684 |
| End Cash Position | 10,647 | 12,385 | 13,315 | 12,897 | 11,218 |
| Net Cash Flow | $-2,250 | $-513 | $418 | $3,213 | $1,534 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,990 | -553 | 343 | 1,140 | -1,465 |
| Capital Expenditure | -410 | -109 | -59 | -581 | -433 |
| Free Cash Flow | -2,400 | -663 | 284 | 559 | -1,898 |